Blood Cancer Data Ignore Sex; Cancer Biosimilars Take Off; Mixed Prevention News

(MedPage Today) -- In a review of 182 cancer studies, authors failed to report outcome data by sex in 90% of cases, even though men develop hematologic malignancies more often than women and the diseases progress differently in the sexes. (British...